Evidence map›Paper›PMID 36293277›Full record

ArticleInternational journal of molecular sciences2022

Nuclear Receptor and Stress Response Pathways Associated with Antineoplastic Agent-Induced Diarrhea.

Mashiro Okunaka, Daisuke Kano, Yoshihiro Uesawa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mashiro OkunakaDepartment of Medical Molecular Informatics, Meiji Pharmaceutical University, Kiyose 204-8588, Japan.
Daisuke KanoDepartment of Pharmacy, National Cancer Center Hospital East, Kashiwa 277-8577, Japan.
Yoshihiro UesawaDepartment of Medical Molecular Informatics, Meiji Pharmaceutical University, Kiyose 204-8588, Japan.ORCID 0000-0002-5773-991X
Meiji Pharmaceutical University · JPNational Cancer Center Hospital East · JP

Funding

Japan Society for the Promotion of Science 22K06707
6 · The paper itself

Abstract

In severe cases, antineoplastic agent-induced diarrhea may be life-threatening; therefore, it is necessary to determine the mechanism of toxicity and identify the optimal management. The mechanism of antineoplastic agent-induced diarrhea is still unclear but is often considered to be multifactorial. The aim of this study was to determine the molecular initiating event (MIE), which is the initial interaction between molecules and biomolecules or biosystems, and to evaluate the MIE specific to antineoplastic agents that induce diarrhea. We detected diarrhea-inducing drug signals based on adjusted odds ratios using the Food and Drug Administration Adverse Event Reporting System. We then used the quantitative structure-activity relationship platform of Toxicity Predictor to identify potential MIEs that are specific to diarrhea-inducing antineoplastic agents. We found that progesterone receptor antagonists were potential MIEs associated with diarrhea. The findings of this study may help improve the prediction and management of antineoplastic agent-induced diarrhea.

Indexed as

Antineoplastic AgentsReceptors, ProgesteroneDiarrheaHumansPharmaceutical PreparationsQuantitative Structure-Activity RelationshipUnited StatesAntineoplastic AgentsPharmaceutical PreparationsReceptors, Progesteronecancerdrug-induced diarrheamolecular initiating event

Identifiers

PMID36293277
PMCPMC9604027
OpenAlexW4306659135

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.